Anbio Biotechnology (NNNN) Receivables - Other (2025)
Anbio Biotechnology's (NNNN) quarterly Receivables - Other came in at $948.0 in Q4 2025.
Anbio Biotechnology (NNNN) Receivables - Other (2025) Analysis & Trends
Anbio Biotechnology (NNNN) has 1 years of Receivables - Other data on file, last reported at $948.0 in Q4 2025.
- On a quarterly basis, Receivables - Other changed N/A year-over-year to $948.0 in Q4 2025; TTM through Dec 2025 was $948.0, a N/A change from a year earlier, with the FY2025 full-year figure at $948.0, changed N/A from the prior year.
- Receivables - Other for Q4 2025 stood at $948.0.
- Over the last five years, Receivables - Other for NNNN reached as high as $948.0 in Q4 2025 and fell as low as $948.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Anbio Biotechnology | 425.37 Mn | 413.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 948.00 |
| Dec 31, 2025 | 948.00 |